SELLAS Life Sciences
14 hedge funds and large institutions have $1.63M invested in SELLAS Life Sciences in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
22% more capital invested
Capital invested by funds: $1.33M → $1.63M (+$298K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.27% less ownership
Funds ownership: 6.79% → 6.52% (-0.27%)
13% less funds holding
Funds holding: 16 → 14 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$587K |
| 2 |
EH
Equitable Holdings
New York
|
+$165K |
| 3 |
MML Investors Services
Springfield,
Massachusetts
|
+$30.2K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.59K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$822 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$98K |
| 2 |
Squarepoint
New York
|
-$95K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$65.7K |
| 4 |
Renaissance Technologies
New York
|
-$42K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$35K |
SLS Hedge Fund Activity: Q3 2020 in Review
14 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q3 2020, worth a combined $1.63M — up 22% from $1.33M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SLS and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Worth Venture Partners, opening a new position worth an estimated $587K. The largest seller was Virtu Financial, exiting entirely with an estimated $98K sold.
- 14 institutional investors held SELLAS Life Sciences (SLS) as of Q3 2020, down from 16 in Q2 2020.
- Funds reported $1.63M of SELLAS Life Sciences stock for Q3 2020, up 22% quarter-over-quarter.
- 3 funds opened new SELLAS Life Sciences positions in Q3 2020 and 5 closed out, a net change of -2 holders.
- The largest SELLAS Life Sciences buyer in Q3 2020 was Worth Venture Partners, an estimated $587K added.
- The largest SELLAS Life Sciences seller in Q3 2020 was Virtu Financial, an estimated $98K sold.
Based on aggregated 13F filings for Q3 2020.